Allevi, Inc.
Allevi creates tools and solutions to design, engineer and build with life. Our 3D bioprinters and bioinks are used around the world to find solutions to humanity’s most difficult problems – to cure disease, to test novel drugs, and to eliminate the organ transplant waiting list. Founded in 2014, our mission is to make it easy to design and engineer 3D tissues. We created our desktop 3D bioprinters to be the most versatile, powerful and easy-to-use bioprinters on the market. Allevi is trusted by leading researchers and industry giants in hundreds of labs globally in the fields of tissue engineering, organ-on-a-chip research, pharmaceutical validation, biomaterial development, and regenerative medicine.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
About us
We believe everyone has the potential to change the course of medicine for the better. What will you build?
Allevi builds tools to design and engineer with life. Our 3D bioprinters and bioinks are used by leading researchers worldwide to find solutions to humanity's most difficult problems - to cure disease, to test novel drugs, to eliminate the organ waiting list, to build with life.
3D bioprinting allows researchers to model disease, create custom 3D tissue, and study the body outside the body with a level of control and repeatability that was simply not possible as recently as 5 years ago.
For pharmaceutical development, 3D bioprinting offers a means of testing drugs faster, at a lower cost, and with greater biological relevance than animal testing or 2D in vitro studies.
In the biomedical devices field, 3D bioprinting has enabled new developments such as sugar stents to help surgeons join veins with fewer complications, and systems for improved drug delivery.
Personalized and regenerative medicine continue to grow in popularity, and bioprinting will give doctors and researchers the tools to better target treatments and improve patient outcomes.
Over 110,000 people in the US alone are on the organ transplant waiting list at any given time. There’s a large and growing need for an alternative to organ and tissue donation. 3D bioprinting is an exciting new tool with the potential to eliminate the organ transplant waiting list
